In Stock

TiterSafe Influenza B (Victoria)

SKU:
HAP-1302
Maximum Purchase:
10 units
Current Stock:
Virus (Lineage):
Influenza B (Victoria)
Strain:
B/Austria/1359417/2021
Unit:
200µL
Lead Time:
Ready to ship
$755.00
Request a quote, including discounts on bulk orders
HA assay was performed using 1% Guinea Pig RBCs in a 96-well plate. The HA assay was used to determine an Influenza B TiterSafe titer at 4 HA units.
HAI assay was performed using 1% Guinea Pig RBCs in a 96-well plate. The titer at 4 HA units and hyperimmune serum were used to perform the HAI assay. Reported serum dilutions are defined prior to TiterSafe volume addition.
TiterSafe by Integral Molecular, Inc.

Frequently Bought Together:

HA assay was performed using 1% Guinea Pig RBCs in a 96-well plate. The HA assay was used to determine an Influenza B TiterSafe titer at 4 HA units.
Inc. Tax
Ex. Tax

Influenza TiterSafe, an HAI reagent, consists of non-replicative virus-like particles (VLPs) that display influenza HA and NA on a lentivirus core. TiterSafe replaces live virus in the hemagglutination inhibition assay (HAI), the standard assay for testing immune sera to determine to assess serum antibody titers. Protocols are provided for HA and HAI assays, with guinea pig RBCs the recommended target.

Product TiterSafe Hemagglutinating Particles, Influenza B
Catalog Number HAP-1302
Subtype Victoria
Strain Austria/1359417/2021
Expected Dilution to 4HA units 1:64
Red Blood Cells (Not Included) 10% Guinea Pig RBCs
Lead time Ready to ship
Shipping Shipped on dry ice
Storage conditions Store at ≤ -80°C upon receipt
Size 200µL/vial
Packaging DMEM

Related Products